Selected patient and tumor characteristics according to breast cancer subtypes defined by immunohistochemistry.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Selected_patient_and_tumor_characteristics_according_to_breast_cancer_subtypes_defined_by_immunohistochemistry_/298897
下载链接
链接失效反馈官方服务：
资源简介：
*BCP = 75.9% of TNBC.BCP, basal core phenotype; HT, hormonal therapy; MRM, modified radical mastectomy; N, number; RT, radiotherapy; TNBC, triple-negative breast cancer.1p = 0.004, 2p = 0.013, 3p4p 5p = 0.030, 6p = 0.031, 7p8p9pPatients were classified as: luminal A (ER-positive and/or PgR-positive, HER2-negative, Ki67low); luminal B (ER-positive and/or PgR-positive, HER2-negative, Ki67high); luminal-HER2 (ER-positive and/or PgR-positive, HER2-positive); HER2-enriched (ER-negative, PgR-negative, HER2-positive); triple-negative (TNBC) (ER-negative, PgR-negative, HER2-negative); and basal core phenotype (BCP) (TNBC, CK5-positive and/or EGFR-positive).
创建时间：
2015-12-02
